VERTEX PHARMACEUTICALS INC
VRTXNASDAQ🏆 #111 by market capEarnings Nov 2Biotech
$529.65▲ $5.83 (+1.10%)
Market closed · at close1h—
24h▲ 1.1%
7d▲ 9.3%
14d▲ 9.5%
30d▲ 10.3%
1y▲ 36.5%
🏦Market Cap
$134.43B
Mid Cap
📈Revenue Growth (YoY)
+10.2%
Healthy
📊Gross Margin
86.0%
High
💵FCF Margin
29.5%
Strong
⚖️P/S Ratio
10.1x
Elevated
Otter Score
52
Weak
Earnings
Q3 · 2026Reported 2026-08-03Earnings Per Share
Actual
4.73
Expected
4.74
miss
−0.20%
YoY +4.60%
Revenue
Actual
$3.33B
Expected
$3.23B
beat
+3.20%
YoY +12.50%
Consensus estimates
Recent quarters
Q3 2026
4.73
miss
Q2 2026
4.47
beat
Q1 2026
5.03
miss
Q4 2025
4.80
beat